Ronald M. Evans

Source: Wikipedia, the free encyclopedia.
Ronald M. Evans
Born(1949-04-17)April 17, 1949
Los Angeles, California, United States
Alma mater
  • UCLA
Awards
Scientific career
Institutions

Ronald Mark Evans (born April 17, 1949 in

nuclear hormone signaling and their function in metabolism and cancer.[3][4]

He received his

Salk Institute
in 1998.

His work on nuclear receptor was well recognized, thus he is a recipient of more than 40 nationally or internationally acclaimed awards and honors. In 2003 he was awarded the

AAAS fellow in 2018 and a member of the National Academy of Inventors
in 2018. Consistent with the broad impact of his work, he is listed by the Institute of Scientific Information as one of the most cited scientists of the past decade.

Research

Members of the nuclear receptor (NR) superfamily of ligand-regulated transcription factors play important roles in reproduction, development, and physiology. In humans, genetic mutations in NRs are causes of rare diseases, while hormones and drugs that target NRs are in widespread therapeutic use.[9] In 80s, Dr. Evans successfully cloned the first nuclear hormone receptor, the human glucocorticoid receptor. This action led to the finding of a superfamily of nuclear hormone receptors, all with similar molecular and genetic structures. Other of his pioneering studies include investigate hormones’ normal activities and their roles in disease, including a major discovery of nuclear hormone receptors, which respond to steroid hormones, vitamin A, vitamin D, thyroid hormones, and bile acids. By targeting genes these receptors help control sugar, salt, calcium, cholesterol, and fat metabolism. They are primary targets in breast, prostate, and pancreatic cancers and leukemia treatment and have therapeutic roles in chronic inflammation, osteoporosis, and type 2 diabetes and asthma. His muscle metabolism studies led to the discovery of exercise mimetics, which promote the benefits of fitness without training and may help battle the obesity epidemic, diabetes, heart disease, and frailty.

Honors

References

  1. PMID 15090221
    .
  2. .
  3. .
  4. .
  5. ^ "Ronald M. Evans, PhD". The Seaborg Medal. UCLA. Retrieved 24 November 2022.
  6. S2CID 24702502
    .
  7. .
  8. ^ "APS Member History". search.amphilsoc.org. Retrieved 2021-05-17.
  9. PMID 28368290
    .
  10. ^ "Horwitz Prize Awardees". Columbia University Irving Medical Center. 2018-06-20. Retrieved 2019-10-05.
  11. ^ Wolf Prize Ceremony 2012, retrieved 2019-10-05
  12. ^ "Albany Medical College: Previous Recipients". www.amc.edu. Retrieved 2019-10-05.
  13. ^ Prof. Ronald M. Evans - Harvey Prize Recipient 2006, retrieved 2019-10-05
  14. ^ "Ronald M. Evans". Gairdner Foundation. Retrieved 2019-10-05.
  15. ^ "France's highest scientific honor to be awarded this year to Salk Institute scientist Ronald M. Evans". Salk Institute for Biological Studies. Retrieved 2019-10-05.
  16. ^ "Salk scientist awarded Glenn T. Seaborg Medal". Salk Institute for Biological Studies. Retrieved 2019-10-05.
  17. ^ Foundation, Lasker. "Nuclear hormone receptors for regulating genes". The Lasker Foundation. Retrieved 2019-10-05.
  18. ^ "The 2003 Keio Medical Science Prize Awardees - Keio Medical Science Prize(テスト用) - Keio University Medical Science Fund". www.ms-fund.keio.ac.jp. Retrieved 2019-10-05.
  19. PMID 10453358
    .
  20. .

External links